Research on gene expression regulated by long-term erythromycin therapy for chronic respiratory disease
Not Applicable
Recruiting
- Conditions
- chronic respiratory disease
- Registration Number
- JPRN-UMIN000022281
- Lead Sponsor
- Department of Pathophysiology and Host Defense, The Research Institute of Tuberculosis -Japan Anti-Tuberculosis Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who change their medicine except for erythromycin 1 month before treatment and 4~8 weeks after treatment 2)Patients who need to receive standard of care
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method